BI
EW icon

Binnacle Investments’s Edwards Lifesciences EW Stock Holding History

Binnacle Investments’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$21.5K Buy
277
+52
+23% +$4.06K 0.01% 261
2025
Q2 		$17.6K Hold
225
– – 0.01% 248
2025
Q1 		$16.3K Buy
+225
New +$16.1K 0.01% 236

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Binnacle Investments's EW Position: Q3 2025 in Review

Binnacle Investments increased its Edwards Lifesciences (EW) stake by 23% in Q3 2025, buying an estimated $4.06K and bringing the position to 277 shares worth $21.5K. The position accounts for 0.01% of the portfolio, ranked #261.

Binnacle Investments first reported a position in EW in Q1 2025 and has held it in 3 quarters since. 1,253 funds tracked by Wall St. Rank hold EW as of Q3 2025.

  • Binnacle Investments held 277 shares of Edwards Lifesciences worth $21.5K as of Q3 2025.
  • Binnacle Investments bought 52 Edwards Lifesciences shares in Q3 2025, an estimated $4.06K.
  • Edwards Lifesciences made up 0.01% of Binnacle Investments's portfolio in Q3 2025, its #261 holding.
  • Binnacle Investments first reported a position in Edwards Lifesciences in Q1 2025 and has held it in 3 quarters since.
  • 1,253 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Binnacle Investments's 13F filing for Q3 2025, filed 14 Nov 2025.